Stifel Maintains Buy on Disc Medicine, Lowers Price Target to $110

Disc Medicine, Inc. +1.51%

Disc Medicine, Inc.

IRON

65.20

+1.51%

Stifel analyst Stephen Willey maintains Disc Medicine (NASDAQ: IRON) with a Buy and lowers the price target from $125 to $110.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via